UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
NVIDIA has etched itself as a premier growth stock by riding the AI wave and expanding its data-center and software e...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Tesla's delivery numbers blew past expectations, but the market reaction surprised many investors. This article break...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
Wix faced a sharp stock drop after its quarterly results and cautious analyst notes. This article breaks down the fac...
Broadcom has faced a stock pullback even as AI-driven revenue climbs. This article digs into the reasons behind the d...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
This guide breaks down where will palantir stock could land in five years. You’ll find scenarios, risks, and actionab...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...